Benoı̂t Rousseau

6.7k total citations · 2 hit papers
96 papers, 2.7k citations indexed

About

Benoı̂t Rousseau is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Benoı̂t Rousseau has authored 96 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Benoı̂t Rousseau's work include Colorectal Cancer Treatments and Studies (20 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Genetic factors in colorectal cancer (14 papers). Benoı̂t Rousseau is often cited by papers focused on Colorectal Cancer Treatments and Studies (20 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Genetic factors in colorectal cancer (14 papers). Benoı̂t Rousseau collaborates with scholars based in France, United States and Spain. Benoı̂t Rousseau's co-authors include Julien Caldéraro, Alain Luciani, Jean–Michel Pawlotsky, Alexis Laurent, Giuliana Amaddeo, Cécile Charpy, Fouad Lafdil, Cindy Neuzillet, Christophe Tournigand and Daniel Azoulay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Benoı̂t Rousseau

89 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features

2016 351 citations Julien Caldéraro, Benoı̂t Rousseau et al. profile →
Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma

2018 315 citations Julien Caldéraro, Benoı̂t Rousseau et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Benoı̂t Rousseau France	25	1.3k	768	567	559	457	96	2.7k
Kiat Hon Lim Singapore	26	1.0k 0.8×	862 1.1×	624 1.1×	479 0.9×	308 0.7×	69	2.6k
Henghui Zhang China	26	1.1k 0.8×	647 0.8×	770 1.4×	522 0.9×	276 0.6×	111	2.5k
Jun Gong United States	28	2.1k 1.6×	924 1.2×	660 1.2×	843 1.5×	457 1.0×	163	3.4k
Pierluigi Pilati Italy	36	1.8k 1.3×	893 1.2×	453 0.8×	720 1.3×	1.1k 2.5×	139	3.7k
Takashi Kijima Japan	26	1.4k 1.0×	1.3k 1.7×	392 0.7×	1.2k 2.2×	245 0.5×	167	3.4k
Tatsuaki Tsuruyama Japan	29	715 0.5×	988 1.3×	818 1.4×	639 1.1×	644 1.4×	147	3.2k
Enrico N. De Toni Germany	26	1.2k 0.9×	1.3k 1.7×	489 0.9×	613 1.1×	383 0.8×	107	3.5k
Eric T. Kimchi United States	27	1.1k 0.8×	588 0.8×	332 0.6×	504 0.9×	440 1.0×	103	2.1k
Toby C. Cornish United States	30	1.4k 1.1×	1.2k 1.5×	501 0.9×	768 1.4×	482 1.1×	75	3.6k
Ben Vainer Denmark	38	915 0.7×	838 1.1×	900 1.6×	793 1.4×	792 1.7×	128	4.1k

Countries citing papers authored by Benoı̂t Rousseau

Since Specialization

Citations

This map shows the geographic impact of Benoı̂t Rousseau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benoı̂t Rousseau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benoı̂t Rousseau more than expected).

Fields of papers citing papers by Benoı̂t Rousseau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benoı̂t Rousseau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benoı̂t Rousseau. The network helps show where Benoı̂t Rousseau may publish in the future.

Co-authorship network of co-authors of Benoı̂t Rousseau

This figure shows the co-authorship network connecting the top 25 collaborators of Benoı̂t Rousseau. A scholar is included among the top collaborators of Benoı̂t Rousseau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benoı̂t Rousseau. Benoı̂t Rousseau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dousset, L., Benjamin Dartigues, Walid Mahfouf, et al.. (2025). Metabolism-based scoring of cutaneous squamous cell carcinoma to predict tumour features and responses to treatment with dihydroorotate dehydrogenase inhibitors. British Journal of Dermatology. 193(5). 936–947.

Artz, Oliver, Peter Ntiamoah, Caroline Weipert, et al.. (2025). Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer. Clinical Cancer Research. 32(6). 1100–1109. 1 indexed citations

Vienot, Angélique, Déwi Vernerey, Adeline Bouard, et al.. (2025). Stanniocalcin 1 in Patients with Refractory Colorectal Cancer Treated with Regorafenib: A Post Hoc Biomarker Analysis of the TEXCAN and CORRECT Trials. Cancer Research Communications. 5(2). 287–294. 2 indexed citations

Sweeney, Kieran, Paul Johannet, Oliver Artz, et al.. (2025). 111O The mechanism of mismatch repair deficiency (MMRd) informs survival outcomes derived from immune checkpoint blockade (ICB) across MMRd solid tumors. Annals of Oncology. 36. S237–S238.

Hilmi, Marc, Anthony Turpin, Antoine Andremont, et al.. (2024). Association between the antibiotics use and recurrence in patients with resected colorectal cancer: EVADER-1, a nation-wide pharmaco-epidemiologic study. Digestive and Liver Disease. 57(1). 89–96. 1 indexed citations

Johannet, Paul, Henry Walch, Benoı̂t Rousseau, et al.. (2024). Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors. Journal of Clinical Oncology. 42(32). 3847–3857. 5 indexed citations

Foote, Michael B., James R. White, Walid K. Chatila, et al.. (2024). Analysis of Shared Variants between Cancer Biospecimens. Clinical Cancer Research. 31(2). 376–386.

Foote, Michael B., Guillem Argilés, Benoı̂t Rousseau, & Neil H. Segal. (2023). Facts and Hopes in Colorectal Cancer Immunotherapy. Clinical Cancer Research. 29(20). 4032–4039. 5 indexed citations

Allain, Nathalie, Mélanie Moreau, Arnaud Jabouille, et al.. (2022). Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation. Oncogene. 41(18). 2571–2586. 17 indexed citations

10.

Tron, Camille, F. Lemaı̂tre, Thierry Lecomte, et al.. (2022). 449TiP Evaluation of regorafenib treatment PERSOnalization based on therapeutic drug monitoring in patients with metastatic colorectal cancer (mCRC): RePERSO study. Annals of Oncology. 33. S739–S740. 1 indexed citations

11.

Brouillet, Arthur, Trung Nguyen, Benoı̂t Rousseau, et al.. (2022). Interleukin-17 programs liver progenitor cell transformation into cancer stem cells through mir-122 downregulation with increased risk of primary liver cancer initiation. International Journal of Biological Sciences. 18(5). 1944–1960. 16 indexed citations

12.

Neuzillet, Cindy, Andrea Casadei‐Gardini, Bertrand Brieau, et al.. (2020). Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer. International Journal of Cancer. 147(11). 3177–3188. 17 indexed citations

13.

Phelip, Jean–Marc, David Tougeron, David Léonard, et al.. (2019). Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Digestive and Liver Disease. 51(10). 1357–1363. 70 indexed citations

14.

Cohen, Romain, T. Pudlarz, Marc Hilmi, et al.. (2019). Traitement des cancers colorectaux par immunothérapie : aller au-delà de MSI avec la classification moléculaire (CMS) et la charge mutationnelle. Bulletin du Cancer. 106(2). 151–161. 2 indexed citations

15.

Caldéraro, Julien, Benoı̂t Rousseau, Arthur Brouillet, et al.. (2018). Interleukin-17 mediates liver progenitor cell transformation into cancer stem cells through downregulation of miR-122. Cancer Biology and Medicine. 15. 14. 1 indexed citations

16.

Jolivet, Pierre, et al.. (2018). Preconditioned Krylov subspace methods for solving radiative transfer problems with scattering and reflection. Computers & Mathematics with Applications. 77(6). 1453–1465. 15 indexed citations

17.

Beinse, Guillaume, Lauriane Ségaux, C. Tournigand, et al.. (2017). Potential drug interactions in older patients with cancer: Updated data from the ELCAPA cohort survey. Annals of Oncology. 28. v557–v558. 1 indexed citations

18.

Favennec, Yann, et al.. (2015). A wavelet multi-scale method for the inverse problem of diffuse optical tomography. Journal of Computational and Applied Mathematics. 289. 267–281. 9 indexed citations

19.

Fournier, Georges, et al.. (2007). VID-01.09: Laparoscopic radical prostatectomy in a renal allograft recipient: surgical technique. Urology. 70(3). 173–173. 1 indexed citations

20.

Rousseau, Benoı̂t, et al.. (1999). Les effectifs de l'enseignement supérieur de la rentrée 1988 à la rentrée 1998. 1–6.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact